Transforming Stereotactic Radiosurgery with Artificial Intelligence: Toward Intelligent Planning and Streamlined Workflows

Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (hSRT) have become a cornerstone in the management of intracranial lesions, offering high precision and ablative dose delivery in one or a limited number of treatment fractions. As clinical indications continue to expand, patients are increasingly treated for larger numbers of brain metastases in a single course and repeat SRS/hSRT courses for new and/or recurrent lesions have become more common. These evolving treatment paradigms substantially increase planning complexity, as target delineation, cumulative dose assessment, normal tissue sparing, and treatment optimization become increasingly challenging with each additional lesion and prior course of radiation. Despite its clinical success, SRS/hSRT treatment planning and delivery remain resource-intensive, requiring expert-driven target and normal structure contouring, treatment plan optimization, and rigorous quality assurance. Recent advances in artificial intelligence (AI) present an opportunity to enhance the efficiency, consistency, and patient-specific personalization of SRS/hSRT workflows while enabling the safe and scalable implementation of increasingly complex clinical applications. This review examines the current and emerging applications of AI across the entire SRS/hSRT treatment delivery pipeline, including automated image segmentation, delineation of targets and normal tissues, treatment planning, and dose prediction. Additionally, we will explore AI-enabled workflow integration and clinical decision support systems that facilitate multidisciplinary collaboration. Challenges to widespread adoption, such as data inhomogeneity, model interpretability, regulatory considerations, and the need for clinical validation, will also be explored. By summarizing current evidence and identifying key research directions, this review outlines a path toward intelligent, streamlined SRS/hSRT workflows in which AI augments clinical expertise and ultimately improves patient outcomes.

Authors

Institutions

Publication Details

Journal
Current Oncology
Published
2026-11-11
DOI
https://doi.org/10.3390/curroncol33110696
Primary Topic
Advanced Radiotherapy Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transforming Stereotactic Radiosurgery with Artificial Intelligence: Toward Intelligent Planning and Streamlined Workflows

Simon Shek-Man Lo, Alexander R. Podgorsak, Michael T. Milano, John Kang et al.
Current Oncology
Advanced Radiotherapy Techniques
article

Transforming Stereotactic Radiosurgery with Artificial Intelligence: Toward Intelligent Planning and Streamlined Workflows

Simon Shek-Man Lo, Alexander R. Podgorsak, Michael T. Milano, John Kang, Dandan Zheng, Sara Hardy
article en

Abstract

Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (hSRT) have become a cornerstone in the management of intracranial lesions, offering high precision and ablative dose delivery in one or a limited number of treatment fractions. As clinical indications continue to expand, patients are increasingly treated for larger numbers of brain metastases in a single course and repeat SRS/hSRT courses for new and/or recurrent lesions have become more common. These evolving treatment paradigms substantially increase planning complexity, as target delineation, cumulative dose assessment, normal tissue sparing, and treatment optimization become increasingly challenging with each additional lesion and prior course of radiation. Despite its clinical success, SRS/hSRT treatment planning and delivery remain resource-intensive, requiring expert-driven target and normal structure contouring, treatment plan optimization, and rigorous quality assurance. Recent advances in artificial intelligence (AI) present an opportunity to enhance the efficiency, consistency, and patient-specific personalization of SRS/hSRT workflows while enabling the safe and scalable implementation of increasingly complex clinical applications. This review examines the current and emerging applications of AI across the entire SRS/hSRT treatment delivery pipeline, including automated image segmentation, delineation of targets and normal tissues, treatment planning, and dose prediction. Additionally, we will explore AI-enabled workflow integration and clinical decision support systems that facilitate multidisciplinary collaboration. Challenges to widespread adoption, such as data inhomogeneity, model interpretability, regulatory considerations, and the need for clinical validation, will also be explored. By summarizing current evidence and identifying key research directions, this review outlines a path toward intelligent, streamlined SRS/hSRT workflows in which AI augments clinical expertise and ultimately improves patient outcomes.

Current OncologyVol. 33(11)
University of Washington (US), University of Rochester Medical Center (US), Fred Hutch Cancer Center (US), University of Rochester (US)
Advanced Radiotherapy Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon